The use of validated antibodies are primordial for Breast Cancer research. Let’s see why, and which were the most popular ones in 2015.

Breast cancer arises in cell units whose function is to secrete milk, ducto-lobular breast units, mainly in women, with 89 cases per 100 000 (1). 5 to 10% of these cancers have an inherited genetic origin; 85-90% of cases (known as sporadic or non-hereditary) have environmental origins as yet often unidentified. A significant proportion of sporadic breast cancers is induced by hormonal treatment in women with a predisposition to this type of cancer. Some lifestyle choices (alcohol, trans fats, obesity, lack of exercise) or gynecological (late first pregnancy, not breastfeeding, etc.) also promote cancer.

If detected at an early stage, this cancer can be cured in 9 cases out of 10. Nevertheless, one of the difficulties of curing this disease is to identify the biological characteristics of each patient’s tumor.